Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.6622
+0.0004 (0.06%)
At close: Dec 23, 2025, 1:00 PM EST
0.6749
+0.0127 (1.92%)
After-hours: Dec 23, 2025, 7:30 PM EST
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $34.77 million as of December 23, 2025. Its market cap has decreased by -24.68% in one year.
Market Cap
34.77M
Enterprise Value
-61.74M
1-Year Change
-24.68%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $34.77M, a decrease of -91.85%. That is a compound annual growth rate of -45.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 34.74M | -17.23% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.86B |
| Johnson & Johnson | 499.50B |
| AbbVie | 402.80B |
| UnitedHealth Group | 294.54B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.92B |
| Abbott Laboratories | 217.70B |